| 9th Apr 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 9th Apr 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 8th Apr 2026 7:00 am |
RNS |
Exdensur approved for CRSwNP in China |
| 8th Apr 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 7th Apr 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 2nd Apr 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 1st Apr 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 1st Apr 2026 3:00 pm |
RNS |
Total Voting Rights |
| 1st Apr 2026 7:00 am |
RNS |
ViiV completes changes to minority shareholding |
| 1st Apr 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 31st Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Mar 2026 7:05 am |
RNS |
Bepirovirsen accepted for review in China |
| 30th Mar 2026 7:00 am |
RNS |
Exdensur approved for severe asthma in China |
| 30th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 27th Mar 2026 7:00 am |
RNS |
Bepirovirsen accepted for review by the EMA |
| 27th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 26th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 25th Mar 2026 1:00 pm |
RNS |
Notice of AGM |
| 25th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Mar 2026 3:00 pm |
RNS |
Admission to Trading |
| 23rd Mar 2026 7:00 am |
RNS |
GSK Lung Cancer ADC Gets Japan Orphan Drug Status |
| 23rd Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 20th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 19th Mar 2026 12:00 pm |
RNS |
Lynavoy (linerixibat) approved by US FDA |
| 19th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Mar 2026 10:31 am |
RNS |
US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 10:31 am |
RNS |
US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 12th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
